171 related articles for article (PubMed ID: 18032699)
1. Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.
McNamara PJ; Murthy P; Kantores C; Teixeira L; Engelberts D; van Vliet T; Kavanagh BP; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L205-13. PubMed ID: 18032699
[TBL] [Abstract][Full Text] [Related]
2. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
[TBL] [Abstract][Full Text] [Related]
4. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
[TBL] [Abstract][Full Text] [Related]
5. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.
Lee AH; Dhaliwal R; Kantores C; Ivanovska J; Gosal K; McNamara PJ; Letarte M; Jankov RP
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):61-73. PubMed ID: 23947621
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
[TBL] [Abstract][Full Text] [Related]
8. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.
Casey DB; Badejo AM; Dhaliwal JS; Sikora JL; Fokin A; Golwala NH; Greco AJ; Murthy SN; Nossaman BD; Hyman AL; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H184-92. PubMed ID: 20435851
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.
Nagaoka T; Fagan KA; Gebb SA; Morris KG; Suzuki T; Shimokawa H; McMurtry IF; Oka M
Am J Respir Crit Care Med; 2005 Mar; 171(5):494-9. PubMed ID: 15563635
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
[TBL] [Abstract][Full Text] [Related]
11. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
Lopez NC; Ebensperger G; Herrera EA; Reyes RV; Calaf G; Cabello G; Moraga FA; Beñaldo FA; Diaz M; Parer JT; Llanos AJ
Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1053-63. PubMed ID: 26911462
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
13. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.
Fujita H; Fukumoto Y; Saji K; Sugimura K; Demachi J; Nawata J; Shimokawa H
Heart Vessels; 2010 Mar; 25(2):144-9. PubMed ID: 20339976
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats.
Tourneux P; Markham N; Seedorf G; Balasubramaniam V; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1103-11. PubMed ID: 19837849
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
16. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.
Chrissobolis S; Budzyn K; Marley PD; Sobey CG
Stroke; 2004 Sep; 35(9):2200-5. PubMed ID: 15256679
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction.
Zwissler B; Welte M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):283-9. PubMed ID: 7669961
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.
Fagan KA; Oka M; Bauer NR; Gebb SA; Ivy DD; Morris KG; McMurtry IF
Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L656-64. PubMed ID: 14977625
[TBL] [Abstract][Full Text] [Related]
19. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
[TBL] [Abstract][Full Text] [Related]
20. Analysis of pulmonary vasodilator responses to SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a novel aminofurazan-based Rho kinase inhibitor.
Dhaliwal JS; Badejo AM; Casey DB; Murthy SN; Kadowitz PJ
J Pharmacol Exp Ther; 2009 Jul; 330(1):334-41. PubMed ID: 19369577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
